Ouvrages publiés en collaboration (1)
Articles dans des revues avec comité de lecture (15)
2.
Hamla, S., Sacré, P.-Y., Derenne, A., Cowper, B., Goormaghtigh, E., Hubert, P., & Ziemons, E. (2022). A New Alternative Tool to Analyse Glycosylation in Monoclonal Antibodies Based on Drop-Coating Deposition Raman imaging: A Proof of Concept. Molecules, 27(14), 4405. doi:10.3390/molecules271444053.
Hamla, S., Sacré, P.-Y., Derenne, A., Derfoufi, K.-M., Cowper, B., Butré, C. C., Delobel, A., Goormaghtigh, E., Hubert, P., & Ziemons, E. (2022). A new alternative tool to analyse glycosylation in pharmaceutical proteins based on infrared spectroscopy combined with nonlinear support vector regression†. Analyst, 147(6), 1086-1098. doi:10.1039/d1an00697e4.
Derenne, A., Derfoufi, K.-M., Cowper, B., Delporte, C., Butré, C. C., & Goormaghtigh, E. (2021). Analysis of Glycoproteins by ATR-FTIR Spectroscopy: Comparative Assessment. Methods in molecular biology, 2271, 361-374. doi:10.1007/978-1-0716-1241-5_255.
Derenne, A., Derfoufi, K.-M., Cowper, B., Delporte, C., & Goormaghtigh, E. (2020). FTIR spectroscopy as an analytical tool to compare glycosylation in therapeutic monoclonal antibodies. Analytica chimica acta, 1112, 62-71. doi:10.1016/j.aca.2020.03.0386.
Mignolet, A., Derenne, A., Smolina, M., Wood, B., & Goormaghtigh, E. (2016). FTIR spectral signature of anticancer drugs. Can drug mode of action be identified? Biochimica et biophysica acta. Proteins and proteomics, 1864(1), 85-101. doi:10.1016/j.bbapap.2015.08.0107.
Berger, G., Leclercqz, H., Derenne, A., Gelbcke, M., Goormaghtigh, E., Neve, J., Mathieu, V., & Dufrasne, F. (2014). Synthesis and in vitro characterization of platinum(II) anticancer coordinates using FTIR spectroscopy and NCI COMPARE: A fast method for new compound discovery. Bioorganic & medicinal chemistry, 22(13), 3527-3536. doi:10.1016/j.bmc.2014.04.01710.
Derenne, A., Van Hemelryck, V., Lamoral-Theys, D., Kiss, R., & Goormaghtigh, E. (2013). FTIR spectroscopy: a new valuable tool to classify the effects of polyphenolic compounds on cancer cells. Biochimica et biophysica acta, 1832(1), 46-56. doi:10.1016/j.bbadis.2012.10.010